Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial.

ABSTRACT:

SUBMITTER: Xia S 

PROVIDER: S-EPMC8443232 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature